203 related articles for article (PubMed ID: 22986000)
1. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway.
Li J; Li P; Zhang Y; Li GB; Zhou YG; Yang K; Dai SS
Cell Signal; 2013 Jan; 25(1):159-67. PubMed ID: 22986000
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 inhibits c-Ski signaling to promote the proliferation of rat vascular smooth muscle cells.
Li J; Zhao L; He X; Yang T; Yang K
Cell Signal; 2014 Apr; 26(4):724-9. PubMed ID: 24388835
[TBL] [Abstract][Full Text] [Related]
3. The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop.
Liu X; Li P; Liu P; Xiong R; Zhang E; Chen X; Gu D; Zhao Y; Wang Z; Zhou Y
Biochem J; 2008 Jan; 409(1):289-97. PubMed ID: 17725545
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways.
Suwanabol PA; Seedial SM; Shi X; Zhang F; Yamanouchi D; Roenneburg D; Liu B; Kent KC
J Vasc Surg; 2012 Aug; 56(2):446-54. PubMed ID: 22521802
[TBL] [Abstract][Full Text] [Related]
6. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells.
Si H; Grgic I; Heyken WT; Maier T; Hoyer J; Reusch HP; Köhler R
Br J Pharmacol; 2006 Aug; 148(7):909-17. PubMed ID: 16770324
[TBL] [Abstract][Full Text] [Related]
8. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation.
Tsai S; Hollenbeck ST; Ryer EJ; Edlin R; Yamanouchi D; Kundi R; Wang C; Liu B; Kent KC
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H540-9. PubMed ID: 19525370
[TBL] [Abstract][Full Text] [Related]
10. Gingerol Inhibits Serum-Induced Vascular Smooth Muscle Cell Proliferation and Injury-Induced Neointimal Hyperplasia by Suppressing p38 MAPK Activation.
Jain M; Singh A; Singh V; Maurya P; Barthwal MK
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):187-200. PubMed ID: 26240073
[TBL] [Abstract][Full Text] [Related]
11. CTRP3/cartducin is induced by transforming growth factor-beta1 and promotes vascular smooth muscle cell proliferation.
Maeda T; Wakisaka S
Cell Biol Int; 2010 Jan; 34(3):261-6. PubMed ID: 19947921
[TBL] [Abstract][Full Text] [Related]
12. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
Song H; Guo B; Zhang J; Song C
Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
15. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
[TBL] [Abstract][Full Text] [Related]
16. Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries.
Granada JF; Ensenat D; Keswani AN; Kaluza GL; Raizner AE; Liu XM; Peyton KJ; Azam MA; Wang H; Durante W
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2343-8. PubMed ID: 16141400
[TBL] [Abstract][Full Text] [Related]
17. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
18. Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells.
Yue Y; Li YQ; Fu S; Wu YT; Zhu L; Hua L; Lv JY; Li YL; Yang DL
Biomed Pharmacother; 2020 Jan; 121():109640. PubMed ID: 31810114
[TBL] [Abstract][Full Text] [Related]
19. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
20. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
